NM_001909.5:c.972+9C>G
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate
The NM_001909.5(CTSD):c.972+9C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000042 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00028 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
CTSD
NM_001909.5 intron
NM_001909.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.61
Publications
0 publications found
Genes affected
CTSD (HGNC:2529): (cathepsin D) This gene encodes a member of the A1 family of peptidases. The encoded preproprotein is proteolytically processed to generate multiple protein products. These products include the cathepsin D light and heavy chains, which heterodimerize to form the mature enzyme. This enzyme exhibits pepsin-like activity and plays a role in protein turnover and in the proteolytic activation of hormones and growth factors. Mutations in this gene play a causal role in neuronal ceroid lipofuscinosis-10 and may be involved in the pathogenesis of several other diseases, including breast cancer and possibly Alzheimer's disease. [provided by RefSeq, Nov 2015]
CTSD Gene-Disease associations (from GenCC):
- neuronal ceroid lipofuscinosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- neuronal ceroid lipofuscinosis 10Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -6 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 11-1753985-G-C is Benign according to our data. Variant chr11-1753985-G-C is described in ClinVar as Likely_benign. ClinVar VariationId is 1621172.Status of the report is criteria_provided_single_submitter, 1 stars.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001909.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CTSD | NM_001909.5 | MANE Select | c.972+9C>G | intron | N/A | NP_001900.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CTSD | ENST00000236671.7 | TSL:1 MANE Select | c.972+9C>G | intron | N/A | ENSP00000236671.2 | |||
| ENSG00000250644 | ENST00000636615.1 | TSL:5 | c.972+9C>G | intron | N/A | ENSP00000490014.1 | |||
| CTSD | ENST00000497544.3 | TSL:2 | n.597C>G | non_coding_transcript_exon | Exon 2 of 3 |
Frequencies
GnomAD3 genomes AF: 0.0000425 AC: 6AN: 141062Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
6
AN:
141062
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00000436 AC: 1AN: 229376 AF XY: 0.00 show subpopulations
GnomAD2 exomes
AF:
AC:
1
AN:
229376
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000282 AC: 143AN: 507742Hom.: 0 Cov.: 25 AF XY: 0.000269 AC XY: 74AN XY: 275206 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
143
AN:
507742
Hom.:
Cov.:
25
AF XY:
AC XY:
74
AN XY:
275206
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
3
AN:
13208
American (AMR)
AF:
AC:
0
AN:
35990
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
12706
East Asian (EAS)
AF:
AC:
3
AN:
15996
South Asian (SAS)
AF:
AC:
3
AN:
68882
European-Finnish (FIN)
AF:
AC:
0
AN:
29978
Middle Eastern (MID)
AF:
AC:
0
AN:
3010
European-Non Finnish (NFE)
AF:
AC:
127
AN:
306948
Other (OTH)
AF:
AC:
6
AN:
21024
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.241
Heterozygous variant carriers
0
25
50
74
99
124
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000425 AC: 6AN: 141202Hom.: 0 Cov.: 32 AF XY: 0.0000584 AC XY: 4AN XY: 68528 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
6
AN:
141202
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
68528
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
1
AN:
39572
American (AMR)
AF:
AC:
0
AN:
14400
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
3302
East Asian (EAS)
AF:
AC:
0
AN:
4040
South Asian (SAS)
AF:
AC:
1
AN:
3842
European-Finnish (FIN)
AF:
AC:
0
AN:
8712
Middle Eastern (MID)
AF:
AC:
0
AN:
284
European-Non Finnish (NFE)
AF:
AC:
3
AN:
64184
Other (OTH)
AF:
AC:
0
AN:
2010
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.242
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Neuronal ceroid lipofuscinosis Benign:1
Feb 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.